BCE 2-10 KG ---------60-80 10-15 KG---------45-65 KG---------45-65 15-25 KG---------40-45 KG---------40-45 25-35 KG---------35-40 KG---------35-40 35-60 KG---------30-35 KG---------30-35 >60 KG---------25-30
K+ INFUSION RATE
K& *i7 = 0%02 0%04/; 9t > 0%4/; in ugtts/min mEA K& T9t)* 9* DF
MF= BCE X WT X 15 24 = ugtts/min ( 4 = gtts/min!
164 -1 140 (3%15! (1%18-1! =0%56 @ = 56 9% 9 ;9us ,t *)st 0%5 mEA in )/; 12 mEA in )/2;4
ABSOLUTE RETIC COUNT , t $ ti < t
'ti n$ = ,'C 2 > 2 m9*7sis I 2 BM suss9n
0%5 $ 6%3
'n)* = +, $ 400 & 24 . CF/C)i) = +, $ 800 C+ = +, $ 1200 Mingitis = +, $ 1200 F 12 7nti*)ti9n 15 :;9t9t;)7 20
WBC CORRECTION IN HEM TAP
:E': WBC 5M = WBC 1000 'BC
X
1000
ABG INTERPRETATION
FLUIDS K 20 4 4 13 20 30 35 20 20 20 20
COMPUTATION FOR HYPERNATREMIA
TBW X #t ,tu)* sum ) 1 <si sum ) %g% #t=6%3 ,+)=164 mEA TBW=50 <+)=140 mEA
SURFACE AREA 0-5 "g= #t $ 0%05 & 0%05 6%10 6%10 "g= "g= #t $ 0%04 0%04 & 0%1 0%1 10-15 "g= #t $ 0%03 & 0%2 15-20 "g= #t $ 0%02 & 0%4
Na <5MB 25 <50%3)C* 51 <50%6)C* 102 <50%45)C* <50%?)C* 154 154 :*)in ++ 154 <5@' 130 :*)in @' 130 <5M 40 'E+@ ?0 <5' 40 s9*7t M 40 s9*7t : 25 :@: 48 25 :i)*7 ?0 ?0 :i)*7t :*)in 45
X ')t / #t
• m)7 us :*)in ++ 9 i)**7 *)sm) CONVERTION 9 C= (9F-32! $ 5/? 9 F= (9C $ ?/5! & 32 1 = 15 gtts 1 gtt = 4 ugtts 1 = 60 ugtts
Cl 20 51 102 154 154 10? 10? 40 80 40 20 22 80 36
)&= 1 mA =23 mg K & = 1 mA = 3?%1 mg COMPOSITION OF FLUIDS Na K Cl HCO3 G)sti 50 10-15 150 0 :)n)s 140 5 50-100 100 Bi* 130 5 100 40 *9st9m7 130 15-20 120 25-30
ELECTROLYTE COMPUTA COMPU TATION TION
& K & *i)n = 0%1-0%4 mA/"g <iit= (K<K,! $ #t $ 0%6 M)intn)n= 2 $ #t K 3 $ #t ) T9t)* K = iit & m)intn)n Fu** in99)ti9n 40 mA/@ 9 20 mA/500 K in99)ti9n EX #t =11%5 =11%5 "g DF= :@' )t 100 ugtts/min 2 $ 500 $ 100 /; = 0%4mA K /"g t;9 0%4 $ 11%5 "g = 4%6 t9 in99)t t9 DF 9 5 mA in 500 :@' :@' 500 & 5 mA KC* )t 100 /; T;9 :@' = 2 mA/500 2 & 5 mA mA = mA $ 500 $ 100 = 1%4 mA/ ; 1%4 mA #t9 11%5 "g = 0%12 mA/"/; K & *i)n
1 : i ) 9 t s
164-140= 24 mEA = 48 0%5 mEA/; 56 = 11%8 /; &( 2 *9ss! 48 20 =31%8 /; :*)sm) sm9*)*it7 (+um ) $ 2! & (g*u9s mg/@! 18 C)tinin C*))n K= 0%55 $ t t in m +um ) in mg/@ C) umm9*/@ = mg/@ 88%4 50-60 .TH 25-50 ,C.TE 'E,@ F,@.'E 10-25 C'C 'F I10 E+'< GF' I 20 = :'< ,EM, BLOOD
Rule #! ,n )ut ;)ng in :)C 2 9 1 mmg is )ss9 #/ )n in 9 ) in 9 0%008 units t;us #;n t; :)C2 in)ss J7 10 mmg #i** J7 0%08 units (ins*7 99ti9n)*! > tmin t; s 9m9nnt 9 )i-J)s J)*)n
T9 )sss t; s 9m9nnt 9 )i- J)s J)*)n 1% )*u*)t t; )m9unt J7 #;i; t; 9t :)C 2 it; )**s J*9# 9 $s 40 mmg% mmg% +uJt)t t; )tints :)C2 9m 40 mmg 2% it t; J)s 9n t; m)su :)C 2 )g t9 u* 1 3% 9m) t; m)su #/ t; it L i t; it is Au)* t9 t; m)su )** ;)ng in t; ) s in 9igin L i t; m)su is > t;)n t; it )n )ss9% mt)J9*i )*")*9sis is snt L i t; m)su is I t;)n t;)t it 9m 9m t; :)C2 )n )ss9% mt)J9*i )i9sis is snt%
D@.ME J (<J- ,J! $2 $ #t t (<t ,t! $ #t :)" 'BC = 10/"g in 4 ;9us :': = 10-15 /"g in 2-4 :*)t*t 9n% = F)st i 1u/10KBW 1u/10KBW 1 unit = 30 #i** )is *)t*t J7 10000 Fs; W;9* B*99 = 20/ m)$% D9*um D9*um (<- ,J! $ 2 $ 3 $ #t (< ,;t! $ #t ')t = 9*% X 12 gtts/m* 60 min% $ 4 = gtts/min% <$t)n gin n9t > 20/"/24 DOUBLE VOLUME EXCHANGE TRANSFUSION
= KBW $ E+T% B*99 9*% X 2 M)ti)*s 1%GT F% F% 5 1 (umJi*i )t;%! F% 81 (9 GT! 2% t; #)7 st9 9" 3% FWB 4% sutu 5% 50 s7ing 6% )*ium g*u9n)t % GT sti :,'T,@ EXC,GE TRANSFUSION = KBW $ E+T% B@< D@% X (,t <t! ,tu)* t L ( ,ti)* *in!
;)ng #it; 0%01 units is t; su*t 9 Rule # "! , ) J)s ;)ng 9 0%6 mEA/@ t;9 in 9 J7 0%15 units 9s9ning 9s9ning in 9 in J)s J)s J7 10 mEA/@ ( it*7 99ti9n)*! > t; i Jt )* N m)su (,BG su*t! $ 2/3 (0%66! mEA/@ is Au)* t9 J)s $ss > i BE is >4 it; &/- ,J &4 mt% )*")*9sis - 4 mt% )i9sis B 45 ,*" > %45 I 35
E$ C2 = 50 mmg = %26 'u* 1
50 - 40 = 10 10 = 10 0%8 $ $ = 0%08 %40 0%08 0%08 = %32
C3 22-26 I 22 > 26
,tu)* m)su %26 %32 = - 0%06 B
TF' = #t $ TD (10-15! $ '' $ E ')ti9 (2! & 2000 (2@! Fi2 = C, (0%2! & 2(! $ 100 TF' C, = 100 Fi 2 $ TF' ? 2 = F' C, Ma$e%&al' (ee)e)! C)n 7-tuJing uJJ tuJings g*)ss tuJings 1@ J9tt* #/ )*iJ)ti9n #/ g*)ss tuJing inst int9 t; 9 C9mss )i :u*s 9$imt FORMULA! F%'% = TD $ #t $ '' $ E & 2000 1000
#; F' = *9# )t TD = ti)* 9*um B 6-10 /"g C;i* 10-15 /"g ,u*t 15 /"g E = 2 <) s) = 2000 '' = 40-60 n9m)*! %g% B :T BW= 1%2 "g F' = 6 $ 1%2 $ 40 $ 2 & 2000 1000 =3 C, & 2 tmin Fi2 J7 )ssssing )tint *us CX' sti s;9#ing #;it 9ut 9n CX' in)s Fi 2 t9 100 ?0 C, = 100 Fi 2 $ F' ? = 100- ?0 $ 3 = 0%4 @ ? 2 = F' C, = 3 0%4 = 2%6 @/min T;niAu
2 : i ) 9 t s
1% "in" C, tuJ )Qust 2 g)ug ) )t u J9tt* unti* 2%5 @ (n i g)ug )s 6@! 2% 9n C, )Qust C, t9 m)" u J9tt* ); 3@ 9m)* :)2 FT 60-80 :T 50-60 M9nit9 1% ,BGs )t 7 ;)ng in stting i )siJ* 2% )tints 9niti9n L #it; :)2 >100 Fi 2 g)u)**7 #;i* ;"ing )tint t BGs )t 15-30 min GUIDELINES 1% initi)**7 C:,: is st )t 6 m #)t% t; is n9 in in :2 in 15 min ssu must J in)s in 2 m inmnts t9 ) m)$imum 9 10 m (i J7 ETT! 9 J7 12 m (in 9t; mt;9 2% t; is )n in in :)2 u ssu% 3% 10-12 m #t ssu is )tt)in )n i :) 2 m)ins un 50 Fi 2 must J in)s J7 5-10 inmnts 4% C:,: )i*u is int i :)2 m)ins *ss t;)n 50 in 100 Fi2 #it; 10-12 m #)t
L C:,: )i*s un n9nin)simt;9 )n ETT must J inst L C:,: )i*s #/ ETT m;)ni)* nti*)ti9n is ini)t T%*ule ',**$&(-! 1% 99 nt7 in *9# )t 2% 't)ining C2 )nn9t t9*)t C:,: - )mJuJ)g t9 J*9# 9 $ss 2 - )*#)7s suti9n J9 C:,: ,BG Wea(&(- .%*/ CPAP 1% Fi2 J7 3-5 7 tim :)2 >0 2% #it; Fi2 9 40 u ssu J7 inmnts 9 2 m #)t 7 2-4 unti* ssu 9 2-3 m is );i 3% t)ns )tint t9 9$7gn ;99 #/ Fi2 9 15-50 Pa%a/e$e%' $* e Me$ Be.*%e Wea(&(1% im9mnt in CX' 2% ,BG s;9#ing :2 >/= 50 mmg 3% B*99 >/= %3 4% :C2 I/= 55mmg 5% gJ 12-15 g 9 ;t 36-45
O"!CA Fl*0 Ra$e 12/ H "O
Fi2 4m 6 40 13 1%%54%5 50 1%52%5 24 60 22 33 0 2%51%5 42 80 31 41%5 ?0 3%50%5 51
8 10 12 26 2%5%5 3? 35 46 4%5%5 44 55 66 53 64 %54%5 62 2%5 43 1 ?1 10%51%5
A%%a(-e/e($ *. CPAP C*/4%e''e) a&% R / S R O"
Pa$&e($
B*$$le
EMERGENCY MEDS
,t9in D/M 0%01-0%03 MK 10-15 min M)$ 9s 0%04MK
ETT 0%01-0%03MK J7 1 ++ : 0%02-0%0? MK A 4-6 )*9$9n 0%1 MK :*)in 0%4/1 9n)t)* 0%02/1 C)t9i* 0%01-0%05 MK : 12 - )minist 1 J9 ing Capoten 25 mg/t)J @-C)nitin 30-40 MK A8 Carnicor : 1g/10 U 330 D 1g/5 7)*)Vin D 0%1-0%5 MK A6-8 M)$ 2 MK A6 : 0%25-1 MK A6-8 ,min #/ 99 Apresoline D 20/)m : 1025/t)J @i9)in niti)* 0%5-1MK D us; $ 5 min +* n9t $ 5MK M)intn)n D inusi9n 10-15 mg/"g/min .;9*in 2%? mg/m 2/ A8 : iiin 0%5-1 MK ) it9ussi niti)* 0%25-0%5 ug/"/min D i nusi9n M)intn)n I2ug/"/min 7tnsi isis u t9 10 ug/"/min ,n9sin +t)ting 9s 50 ug/" )i D us; n 9s in 50 ug/" A2 min unti* tun sinus ;7t;m M)$ 9s 250 ug/" Adenocard 6 mg/2m* Ein;in 0%01m*/"/
DOPAMINE DRIP
1-5 ug/"/min D
C9nnt)ti9n 200 = 0%25 9) & 4?%5 <5W 400 = 0%5 9) & 4?%5 <5W 800 = 1%0 9) & 4? < 5W ')t = '< $ #t $ 60 C9n DOBUTAMINE DRIP
1000 2000 4000
4 8 16
"89:"
46 42 34
,< = )t $ 9n Wt $ 60 ')t = '< $ #t $ 60 C9n DIA;EPAM DRIP 0%3MK i*ut in ++ t9 m)" 0%1 mg/m* '< 0%03-0%04 m/"/min : 10/2 m* 9n% Mg m* + %g% #t=2%8 "g 100 /"/ ugtts/min 4 )ms & ?2 + 40 = 0%4mg/m* (8 m*!
')t= '< $ #t $ 60 C9n = 0%03 $ 2%8 $ 60 0%4 = 12%6 (12-13 ugtts/min!
,<= ')t $ C9n Wt $ 60 = 12%5 $ 0%4 2%8 $ 60 = 0%02? 0%03 m/"/min
EPINEPHRINE DRIP 0%1%1 M/K/M
: C9n = ,MT E: $ 1000 ,MT DF C9n 20 = 1 )m i & 4? < 5W 40 = 2 )m i & 48 < 5W 60 = 3 )m i & 4 < 5W F,T 6 $ #t $ '< ')t = i t9 J ) t9 100 <5W DIGITALI;ATION
0%04-0%06 m/" T<< n9t gin i ' I 100/min Lanoxin 0%05/m* *i$i 0%25 t)J 0%5/2 D %g% #t=2%65 "g = 0%04 $ 2%65 "g 4 =gin 4$ in 24 (A 6 P 9 T<
L 1-2 %"/9s A8 L1 = ? mg *m C) INDOMETHACIN D )t 12-24 int)* niti)* 0%2 m/"g 2n I 48 = 0%1 m" 2- < = 0%2 m" > 8 < = 0%25 m" 3 I 48 = 0%1 m" 2- < = 0%2 m" > 8 = 0%25 m"
ANTICONVULSANT
3 : i ) 9 t s
Tegretol 100/5U 200 C*9n)V)m 0%01-0%03 MK< F9 B)* @< 0%08 MK M< 0%08 MK< A12 Rivotril 2/t)J D)*9i ,i 15MK< Depakene 250/5 Epival 250/t)J @9)V)m 0%05-0%1 MK M)$ 0%4 MK Mi)V9*)m D 0%05-0%15 MK A 2-4 D inusi9n 0%01-0%06 m/"/ (10-60ug/"/! nt)n)s)* 0%2-0%3 MKU 5mg/m* +uJ*ingu)* 0%2-0%3 MKU 5mg/m* )* 0%3-0%5 MK M9;in 0%05-0%2 MK A4 D inusi9n @< 100 ug/" $ 1 M< 10-15 ug/"/ 9stigmin M7)st;ni) g)is 0%1 mg M (gi 30 min J9 ing! 1 mg : ( gi 2 J9 ing! 's)* 9 nu9musu*) J*9") 0%04-0%08 m/" D in )iti9n t9 )t9in 0%02 m/" C;*9)* ;7)t 25-5 MK 50 mg/m*U 100 mg/m* 324U 500U 648 :nt9J)Jit)* 2-6 MK 50 mg/m* PARACETAMOL 8="9 MK) ,Jin 120/5U 325U500 Bigsi 100/m*U250/5U500 C)*9* 120/5U250/5 C9in 125/5U500 <J9* 60/0%6U120/5 )$ 250/5U300/2 '$i9* 150/5U600 Tm) 120/5U250/5 T7*n9* 120/5 Win)9* 120/5U500 ,"ni* 300/2 gsi 125U250 su SALICYLATES ,nti-;um)ti 65-130 MK< ,s) 81 ,sitin 325 9-9)*in 325 +uin 180/5U 3 g ,siin G D (1g = 65 mg!
ANALGESICS Mn)mi )i 3-5 MK Ponstan 50/5 )*Ju;in 0%1-0%15 MK u!ain 10/m* :)nu9nium 0%04-0%15 MK A1-2 Fnt)n7* *9# 2ug/"/ m9 2-20 ug/"/ ;ig; 20-50 ug/"/ nusi9n )t 1-5 ug/"/ ,nst;si) 5-50 ug/"/ "u!limaze #$anseen% 60 ug/2 :9mt;)Vin P&energan D 50/2 : i/U10 Miin 0%5-1%5 MK M)$ 2 MK DU 4 MK : Demerol Ju9n10-15 MK< T< Dolan 100/5 ANTI=ASTHMA ,min9;7**in @< 4-6 MK M< 1%5-3 MK 8-12 7 s*9# DTT t9 J i*ut #/ Au)* )m9unt 9 ist #)t% F9 9* in)nt 9s)g m)7 J in t9 25-30 MK< A4-8 Li ;)nging D t9 : )min9;7**in in 9s J7 20 L9m D t9 : T;9;7**in n9 )Qustmnt <': 0%4-0%? MK
9# t9 i %g% 5"g )t 0%4 MK in 8 i 5 $ 0%4 $ 8 = 16 mg in 8 i DF )t is 5 / i** ++ #/ 40 DF & 16 mg ,min9 (0%64 m*! T;9;7**in 3-5 MK A8 eullin 80/15U 50U 125U250 TJut)*in + 0%005 MK : 0%05 MK <i 0%003 MK 'rican(l D 0%5/m* : 1%5/5U 2%5 J 5 mg/2 +)*Jut)m9* 0%15 MK Ventolin 2/5 s7U 1%2/5 $U 2/t)J J 2%5 mg/2%5 m* Li!rentin 2/5U 2/t)J Prox)" 2/5 ,t9nt 4 gtts/m* ++ 0%4-1 m* T<-< B9u)* nJ 4-10 gtts & 3 ++ )*tn)t #/ TtJut)*in n u t9 A 2 B99t nJ A 12
COUGH ,mJ9$9* 1%2-1%6 MK< A 12 *ucosolvan 15/5U %5/5 +o!rixol 15/5U 6/1U %5/1%5 Am!rolex 15/5 B9m;$in -12 79 1 ts T< 2-6 79 O ts T< 'romulex 4/5U 8mg/t)J 'isolvon 0%8 mg/m* *i$i 2 mg/m* s9*n 4 mg )m +CMC 20-30 MK< Loviscol 50/m* 9s 100/5 250/5 "olmux 40/m* 9s 200/5 sus
:C G B 50-100 T . A12 J79n B 100-200 T . A6 Mningitis 200-400 T . A6 C9ngnit)* +7;i**is 50 T. 625 mg= 1M . 250/5 = 400T. 312%5/5= 500 T. 500 mg= 800 T. )* :C 50-100 MK< Pentacillin 50/5U 500 "umapen 25/5U 250U 500 *egapen 50/m* 9s 312/5 625 ,m9$ii**in 60-?0 MK< A8 Pediamox -lamox .imox *oxillin ,m9$/C*)u*)ni ,i 40-60 MK<
Augmentin 312%5/5 T< 228%5/5 B< Amoclav 312%5/5 )i**in 100-200 MK< A 6 25-50 MK 2? #"s (0-28)7s! A12 (>28 )7s! A8 30-36 #"s (0-14 )7s! A12 (>14 )7s! A8 3-44 #"s (0- )7s! A12 (> )7s! A8 Y45 #"s A6 "ta,loxin 100-200 MK< ,mii**in 100-200 MK< B))mii**in 25-50 MK< Penglo!e 200/5 D)n9m7in 40-60 MK< 2? #"s 20 MK A24 30-33 #"s 20 MK A18 34-3 #"s 20 MK A12 38-44 #"s 15 MK A8 Y45 #"s 10 MK A6 L 9nstitut 500 mg i)* #/ 10 sti* #)t 9 inQti9n t9 m)" ) in)* 9n 9 50mg/m*% +9*n is st)J* 9 14 )7s% $)i**in 50-100 MK< 25-50 MK 2? #"s (0-28 )7s! A12 (>28 )7s! A8 30-36 #"s (0-14 )7s! A12 (>14 )7s! A8 3-44 #"s (0- )7s! A12 (> )7s! A8 Y45 #"s A6 L '9nstitut 1 g i)* #/ 5% sti* #)t t9 m)" ) in)* 9n 9 16 mg/m*% +9*n is st)J* 9 3 )7s )t 99m tm )7s Prostap&lin 125/5 /r!enin 125/5U 250U 500 CEPHALOSPHORINS F&%'$ Ge( C;)*$in 50-100 MK< Ceporex 125/5U 250/5 "elze,0 1e,lex C)9$i* 25-50 MK< B< C)V9*in 50-100 MK< A6-8 "tance, 500 mg 1 g i)* C)in 25-50 MK< A6 Se2*() Ge( Cu9$im 50-100 MK< A8 D 20 MK< A12 : +innat 125/5U 250/5 +inace, 250U 50U 1%5 g C)m)n9* 50-100 MK< < *andol 500 mgU 1 g i)* C)*9 20-40 MK< A12 Ceclor 50 mg/m* 9s 125/5U 250/5 sus 250 500 mg u*u* T,&%) Ge( Ct)Viim > 3 m9-1 79 80 MK< B< > 2 79160 MK< T28 )7s! A8 30-36 #"s (0-14 )7s! A12 (>14 )7s! A8 3-44 #"s (0- )7s! A12 (> )7s! A8 Y45 #"s A8 2ortum 250U 500 mgU 1 gU 2 g Cti)$9n 50-100 MK < +sis N issmin)t GC 50 MK A24 Mningitis 100 MK @< t;n 80 MK A24 .n9m*i)t GC 9;t;)*mi) 50 MK (m)$ 125 mg! +< Rocep&in 250U 500 mgU 1 g i)* C9t)$im 50 MK GC nti9n 25 MK
4 : i ) 9 t s
GC 9;t;)*mi) 100MK +< > 12 79 1 g B< 2? #"s (0-28 )7s! A12 (>28! A8 30-36 #"s (0-14 )7s! A12 (>14 )7s! A8 3-44 #"s (0- )7s! A12 (> )7s! A8 Y45 #"s A 6 C*)9)n 250U500 mgU 1U 2 g i)* C9)V9n 100-150 MK< B< Ce,o!is 0%5g N 1 g i)* CtiV9$im 40-80MK< B
>$, Ge( Cim I 2 m9s 30 MK< B< > 2 m9s 50 MK< B< (#/9 24 U #/ 34#"s A 24 Amikacide 100/2U 250/2 K)n)m7in 30-50 MK< ti*m7in 30-50 MK< etrom(cin 50/2 T9J)m7in 6-8 mK< Gnt)m7in 4-8 MK< I2? #"s 5 MK A48 30-33 #"s 4%5 MK A48 34-3 #"s 4 MK A36 >38 #"s 4 MK A24 -aram(cin 20U 40U 80/2
SULFONAMIDES '< 8-10 MK< A12 'acidal 80/5 Trizole 80/5 Triglo!e 45/5 'actrim 40/5U 10 80 mg/t)J "eptrin 40/5U 160U 80 mg/t)J "(nermed 40/5 "(nerzole 40/5
( )7s! A6 > 45 #"s A6 MACROLIDES E7t;9m7in 30-50 MK< Er(t&rocin 100/2%5 <+ 200/5 400/5 500/i)* ,Vit;9m7in 10 MK< < $ 3 )7s +it&romax 600/m*U 1200/m* C*)it;9m7in 15 MK< A12 1laricid 125/5 '9$it;9m7in 3-6 MK< A 12 *acrol 150 mg/t)J
mnm 60 MK< A6 9n)t 20-25 MK A12 M9nm 20-40 MK A12 +sis 20 MK A 12 Mningitis N :su9m9n)s n$n 40 MK A8
:i)i**in @ss si9us 100-200 MK< A6 +i9us 200-300 MK< 9n)t 50-100 MK I2? #"s (0-28 )7s! A12 (28 )7s! A8 30-36 #"s (0-14 )7s! A12 (>14 )7s! A8 3-44 #"s (0- )7s! A12 (> )7s! A8 >45 #"s A6
ANTI=TB DRUGS 15-20 MK< T$ 10-15 MK< :$ Trisovit 50/5 icetal 100/5 Prima,ort 100/5 /dina& 150/5 P(ro!in. 150/5 Triso,ort 200/5 Comprilex 200/5
'i)miin 10-20 MK< atricin 200/5 Ric(n 200/5 Rimactane 100/5U 200/5 LMning99mi) 3m9-1 79 5 MK A12 $ 4 9ss 1 79-12 79 10 MK A12 $ 4 9ss )u*t 600 MK A12 $ 4 9ss :7)Vin)mi 20-30 MK< T< P+A)Ci!a 250/5 P&arex P+A25/5 Et;)mJut9* 15-20 MK< < A8 ) Et&am!in 125/5U 200 mg/t)J *(am!utol 200/5 3soetam 150/5 Et&am!in 3. 125U 150/5 Pediam!utol4 Et;)m 125/5 15/5 :7i9$in 6/5 +tt9m7in 20-30 MK< < M
C;9*)m;ni9* 50-100 MK< A6 9n)t @<20 mg/"g M< Jgin 12 )t @< :T I 1 m9 12%5 MK A6 FT I1 #" :T > 1m9 5 MK A6 FT > 1#" 12%5 MK A6 Pediac&lor 125/5 C&lorom(cetin 125/5 C&loramol 125/5 Tt)7*in 40-60 MK< C*in)m7in 30-50 MK< B 5-%5 MK I2? #"s (0-28 )7s! A 12 (28 )7s! A8 30-36 #"s (0-14 )7s! A12 (>14 )7s! A8 3-44 #"s (0- )7s! A8
IRON T$ 4-6 m"< :$ 1-2 m"<
F-in-s9* 15mg/0%6m* 18mg/5m* F*in 30 mg/ m* 15 mg/m* Jt 500 mg 26%25/5m* nmin 30 mg/5m* i9n-C 50 mg/10m* 25 mg/5m* :9*7-i- 10mg/m* :9)n 25 mg/5m*
ANTIDERMATOSIS 799tis9n 1 T< $ 2 #"s 7t9n 79ti EV)9t Bt;)mt;)s9n B<-T< Btn9)t
Mui9in B)t9J)n <s9$imt;)s9n B<-T< Ess9n Eum9)t 9 I 3m9s Cuti)t 9 > 3m9s <)9*n )m 9 i) )s;
ANTI=FUNGAL 7st)tin 0%5-1%0 m* T<-< $ < 1 m*(:T! 2 m* (FT! 9 100 T. A6 *(costain 100 T./m* 500 T./t)J ,;9tiin B niti)* 9s 0%25-0%5 mg/"g M< 0%5-1 mg/" A24 t9 48 50 mg 9# i*ut in 10 m* ist #)t Gis9u*in 10 MK +< F*u9n)V9* +7stmi in$ns in mningitis @< 12 mg/"g M< 6 mg/"g I2? #"s (0-14 141445 #"s A24 T;us; 6 MK )7 1 t;n 3 MK A24 : Di,lucan 2mg/m* 50 150 200 mg/) Kt99n)V9* >30 "g 200 mg < 15-30 "g 100 mg < I 15 "g 5 mg izral 200 mg/t)J
DIURETICS Fu9smi 1-2 MK Lasix 20/2U 40/2U 20U 40/t)J 2rusema 20/2U 2040/t)J
M,T@ 20 1%5-2 g" 9 5 /"g 200 g/@U 1 g=5
,@B.M 0%5-1 g" M)$ 6g* Al!umer al!utren 50/1 (5!U 250/1 (25!
5 : i ) 9 t s
ANTIVIRAL Mt;is9in9sin 50-100 MK< 3soprinosine 250/m*U 500 mg/t)J n9sin9*$ 50 MK< 3mmunosine 250/5 ,m)nt)in 5-8 MK< "(mmetrel 50/5 ,7*9i 1-15 MK< A4 +ovirax 250/5U 200 mg/t)J Di)V9* 10MK< ANTACIDS Cimtiin 1-20 MK< A12 Tagamet s(r 200/10 T)J 200U 400U 800 D 200/2U 300/2 ')nitiin 4-5 MK< A8 +antac D 50/2 : 150/m*U 150 300/t)J Cis)i 0%2 MK< A8 Prepulsid 1 mg/m* M))*9$ 10-15 1 ; )t m)*s N + 9)*usi 1 )t m)*s N + F)m9tiin 0%5 MK A24
ANTISPASMODIC
ANTIHELMINTHICS $)nt* 7)nt* )m9)t '< 10-20 MK +< )t + uantrel 20 mg/m*U 100/5 100 mg/t)J Com!antrin 125/5 125 250/t)J '< >15 79 500 mg 10-14 79 35 mg 5-? 79 250 mg 5 79 125 mg Tt)miV9* 2%5-5 MK +< T*+ 12%5/2%5U 50U 100/t)J MJn)V9* 100 mg B< $ 3< Antiox 20 mg/m*U 100U 500 mg/t)J
ANTIAMOEBIC Mt9ni)V9* 40-50 MK< BI 2"g 15 MK< A12 B>2"g I< 15 MK
2 "g >< 30 MK< A8
D @< 15 MK M< %5 MK A8 2lag(l 125/5U 25U 500 mg D 500/100 "ervizole 200/5 Tini)V9* 50-60 MK < $ 3 )7s 2asig(n 300U 500 Et9)mi 15-20 MK< 1itnos 40 mg/5 m*U 250U 500 +ni)V9* 30 MK 9n #/in 4 9 12 9 ;i*n (4t)Js! 2lagent(l 500 mg/t)J Fu)V9*i9n 5- MK< A8 2uroxone 16%/5
Tacar(l 4/5U 4U8 C*m)stin 0%05 MK< A12 Taveg(l 0%5/5U 1 mg/t)J 2 mg/2 m* )m 79$7Vin 1 MK< 3terax 2 mg/m*U 10U 25 mg/t)J CtiVin Virlix 10 mg/m*U 10 mg/t)J @9)t)in 2-12 79 I30 "g 1 ts < >30 "g 2 ts < Claritin 5mg/5 m*U 10 mg/t)J Kt9tin 9%%25 MK A12 +adec 1 mg/m*U +aditen 0%2 mg/m* STEROIDS <$)mt)s9n 0%15-0%4 MK <)9n 4 mg/m* 799tis9n @< 10 MK M< 5-8 MK +9*u-9t 100/2U 250/2U500 :is9*9n 0% MK +9*um9* 125/2 :nis9n 1-2 MK< B% ,st;m) 1 MK< ;% +7n 60 m/+,/24 n 3-4 i 9ss : 5 mgU 10 mgU : 10
VAMIN 2,*( 2%4 g"< Glu2 5-? mgKm :/@ ;9n 60 g C)* 650 )* G*u 100 g +t)t 9s )t ;9n 0%5 g"<
%g% #t =1 "g 1 $ 0%5 $ 1000 = 8%3 D)min gin 60 in 3 9 #t $ ,
%g% #t =2 "g )t *ii 0%5 g"< (% 10! 2 $ 0%5 $ 100 = 10 m* (10 int)*ii! 10 MORIAMIN S" ? g C/100m* '< $ #t $ 1000 ?0 t9 un in 8-10 L565 ")*/@ VITAMIN A I 5 m9sZZZZ%%50000 . 6 m9s-1 79ZZZ%100000 . 1 79 N uZZZ%%%200000 . L 1 )*=50000 .
179 200000 . )s +< WT
#i in *Js = )g (m9s! & 10 IBW 2-12 m9s = )g in m9s $ 10 (in *Js! 4-5 m9s = 2$ BW 1 79 = 3$ BW 2 79 = 4$ BW 3 79 = 5$ BW 5 79 = 6$ BW 79 = $ BW 10 79 = 10$ BW
<5 = 50 = 0%2 )* <%5= 5 = 0%3 )* = 0%05? <10 = 100 = 0%4 )* = 0%125 <12%5=12%5= 0%5 )* = 0%2 <15 =150 ZZZ%%
GOME; CLASSIFICATION BW I1 79 = ()g in m9s/2! & 3 >1 79 = ()g in 7s $ 2! & 8 (,BW/BW! $ 100 0 = ?1-100 1st g = 5-?0 2n g = 4-60 3 g = I60
MILK DILUTION ,JJ9t = 12 M\ N st* = 11 Cal*%&e' EBM 20 )*/9V +26 @BW 24 )* +imi*) :M 21 En)*) 21 G)in 22 @)tum 21%4 @)t9gn C 20 CHON +26 @BW 2%4 g/* G)in 2%8 @)tum 3%42 EBM 1%6
WATERLOW CLASSIFICATION Wa'$&(-! (,BW/BW 9 t! $ 100 0 = >?0 Mi* = 80-?0 M9 = 0-80 + = I0 S$u($&(-! (,tu)* t/ )* t 9 )g! $ 100 0 = >?0 Mi* = ?0-?5 M9 = 80-?0 + = I80
+@<G +C,@E F 'EG@,' +.@ (<% \% .[! 0%5-1 . $ #t = nsu*in At/)7/5 LM9nit9 CBG 5$/)7 -J)")st -*un; -sn)" -su 2,M J)s*in CBG 150 mg/* L9 7 50-5mg in in CBG ) 1 unit 9 'gu*) nsu*in
HEIGHT t in m = )g (7! $ 5 & 80 t in in; = )g (7! $ 2 & 32 1 79 = 20 in $ B@ 3 79 = 3 t 4 79 = 40 in $ B@ 13 79 = 3 $ B@ FLUIDS W: DHN! I2 79 Mi*ZZZ 50/"g $ 8 M9ZZZ%100/"g $ 8 +ZZ%%150/"g $ 8
>2 79 Mi*ZZZ%%30/"g $ 8 M9ZZZ%% 60/"g $ 8 +ZZZ?0/"g $ 8
%g% #t=20 "g 30 $ 0%5 = 15 ./5 = 3 . >150 mg/* = 3 . 200-24? mg * = 4 . 250-2?? mg/* = 5 . 300-34? mg/* = 6 . 350-3?? mg/* = . 400 mg/* N ] = 8 . LGt t; t9t)* 24 nsu*in 'At J)s 9n t; s*iing s)* t;n 9mut 9 t; s*it 9s nsu*in T;);7% ./, [email protected]+E &4 = 20 . &3 = 15 . &2 = 5 . t)= 0 .
'+ 5 /"g $ 6 9 s9m < +EDE'E < 30 /"g F< I1 79 $ 1 >1 79 $30 min 0 /"g I1 79 $ 5 >1 79 $ 2 O DEXTROSITY 5 = 100 9 m* in s9*n
50 100
= 9 m* 9 < 50W t9 ) t9 DF in s9*n t;n num)t9 & num)t9 $ 100 n9min)t9 n9min)t9 Cal*%&e' &( IVF! <5 5 gm = 1 gm = 20 = 0%2 100 m* 4 )* 100 <%5 %5 gm = 1 gm = 30 = 0%3 100 m* 4 )* 100 <10 10 gm = 1 gm = 40 = 0%4 100 m* GLUCOSE INFUSION RATE 1GIR
')t $ <$t9sit7 $ 10 Wt $ 60 ')t $ <$t9sit7 100 60 $ 100 #t
CM:.T,T F +.@ .= (CBG 200!/10 F C'F = O . CM:.T,T F <,BETC <ET BW = (T in m 100! 10 $ (T in m 100! TC'= BW $ BM' BM' 25= Jst 30= mi* 40= ;)7 45= ;7 C,@'C I 1 m9 1-11 m9 1-2 79 3-8 79 -? 79 10-12 79 13-15 79 18-1? 79
'ET 110-140 )*/)7 110-115 100-110 ?0-100 80-?0 0-80 55-85 45-50
0-6 m9 11 ")*/" 6-12 m9 108 ")*/" 1-3 79 100 ")*/" 4-6 79 ?0 ")*/" -10 79 80 ")*/" 11-14 79(M! 65 ")*/" 11-14 79(F! 55 ")*/" 15-18 79(M! 50 ")*/" 15-18 79(F! 40 ")*/"
:'TE '<,
6 : i ) 9 t s
0-5 m9 8-11 m9 1-6 79 -12 79 13-15 79 18-1? 79
2%5 g/"/)7 2%5-3%0 2%0-2%5 1%5-2%0 1%5 1%0-1%5
0-6 m9 6-12 m9 1-3 79 4-6 79 -10 79 11-14 (M! 15-18 (M!
2%2 g/" 2%0 1%8 1%5 1%2 1%0 0%8
Est% C)*9i 'At 9 )t;-u g9#t; K)*/"/)7 = ")*/" A 9 #t-)g $ i)* #t 9 ;t/ )tu)* #t 9 )g C 'ET = C A 9 #t-)g $ i)* #t 9 ;t/ )tu)* #t 9 )g
CF ,CC
T[:E+ F M.'M.' M<+[+ ,9ti N u*m9 stn9sis :,+[+ M' N T' D+< <,+T@C M+ N ,' +[+/<, :<, n9us ;um :i)itis
G',<G F M.'M.' 7 )int n t9 tun in Auit Jut ;) u9n *)ing stt 9n t; ;st m9)t*7 *9u D *9u D 7 *9u #/ stt )t*7 9 t; ;st D ;) #/9 ;st
G@,+CW CM, +C,@E E7 ning 4 +9nt)n9us 4 DJ)* 9mm)n 3 T9 )in 2 @ 1 Bst M9t9 's9ns 0 s9nt% m9mnt @9)*iV )in Wit;)#s t9 )in <9ti)t igiit7 <J)t igiit7 @
6 6 5 4 3 2 1
Bst DJ)* 's9ns int 9nsi9us 5
5
n9m;nsiJ* 2 @ 1 TT,@ 15 M<FE< CM, +C'E E7 ning 4 +9nt)n9us 4 T9 s; 3 T9 )in 2 @ 1 Bst M9t9 's9ns 9 s9nt m9mnt Wit;)#s t9 t9u; Wit;)#s t9 )in ,Jn9m)* *$i9n ,Jn9m)* $tnsi9n @
6 6 5 4 3 2 1
Bst DJ)* 's9ns 5 C99s J)JJ*s 5 it)J* is 4 Cis t9 )in 3 M9)ns t9 )in 2 @ 1 TT,@ 15 + 8 N )J9 M9 ?-13 +*ig;t 14-15
+EGMET,@ @EDE@ F 'EF@EXE+
C.+G+ T',< niti)**7 in B: ' ''
0 n9 mus* 9nt)ti9n 1 J)*7 tt)J* *i" 2 )ti m9mnt 9 t; J97 #/ g)it7 *imit 3 )ti m9mnt )g)inst g)it7 4 )ti m9mnt )g)inst g)it7 #/ sist)n 5 n9m)* stngt;
C'TE', F' B',
BURNS @LUND BREWER CLASSIFICATION 0-1 1-4 5-? 10-14 15 ) 2%1 1? 15 13 11 Tun" 15%5 15%5 15%5 15%5 15%5 .E ?%5 ?%5 ?%5 ?%5 ?%5 @E 14 15 1 18 1? Gnit)*i) 1 1 1 1 1 AMERICAN BURN ASSN :E<, ,<.@T ) 18 ? .E ? ? Tun" 18 18 @E 14 18 Gnit)*i) 0 1
:E<, METE' + F ET'E B<[ +.'F,CE (M! = (KGJ# $ 4 & ?! & 100 mt sA 9 )) Jun = ( 9 Jun $ M 2! & 100 (MB! '$ H .lu&) %$ *s9n C/)7 = (5000 $ M 2B! & (2000 $ M 2! <* Mun9 /)7 = (2 $ "g $ Jun! & (100 $ "g! /)7 = (0 $ M 2 $ Jun! & (1500 $ M 2! initi)**7 20 /"g/ 9 1-2 t;n 1st 8 = O 9 t9t)* 9mut *ui n$t 16 = m)ining O is gin "() ,% .lu&) %e$ *s9n C/)7 = (4000 $ M2 B! & (1500 $ M 2! <* Mun9 C/)7 = P 9 t; 1st 24 *ui N , 20-30 mA 9 K t;n +t)t 9)* sing
Li >10 BW is *9st s * *9st L 9 n9t $ 4-5 @ 9 *ui ETT +HE ,g (7s! & 4 4 :T 2%5-3%0 unu B 3%0-3%5 unu 6 m9s 3%5-4 unu 179 4-4%5 unu 2 79 4%5-5 unu 4 79 5-5%5 unu 6 79 5%5 unu 8 79 6%0 u 9 unu 10 79 6%5 u 9 unu 12 79 %0 u )9*snt -8 u <t; = intn)* i) $ 3 mm > 279= )g (7! & 12 2 N* BLD Value' ()it @)n! ,GE gJ CT WBC 26-30 #"s 13%4 41%4 4%4 (11! (34%?! (2%! 28 #" 14%5 45 32 #" 15%0 4 Tm(9! 16%5 51 18%1(?-10! (13%5! (42! 1-3 7 18%5 56 18%?(?%4-34! (14%5! (45! 2 #" 16%6 53 11%4(5-20! (13%4! (41! 1 m9 13%? 44 10%8(4-1?%5! (10%! (33! 2 m9 11%2(?%4! 35 (28! 6 m9 12%6 36 11%?(6-1%5! (11%1! (31! 6m9-27 12 36 10%6(6-1! (10%5! (33! 2-67 12%5 3 8%5(5-15%5! (11%5! (34! 6-127 13%5 40 8%5(4%5-13%5! (11%5! (35! 12-187 M 14%5 43 %8(4%5-13%5! (13! (36! F 14%0 41 %8(4%5-13%5! (12! (3! T7 Re-&/e( .*% H 4?l*%& :E<, 1% m)V9* & C*)it;9 & Mt9 $ 2 #"s 2% Mt9 $ 2 #"s & 4 #"s Bismut; suJs)*i7*)t 3% ,m9$ & Bi $ 6 #"s 4% ,m9$ & Tini)V9* $ 6 #"s ,<.@T 1% m)V9* 40 mg < & C*)it;9 T< $ 2 #"s t;n m)V9* 20mg < $ 2 #"s 2% ')nitiin 400mg B< & C*)it;9 T< $ 2 #"s t;n ')nitiin 400mg B< $ 2#"s 3% :t9-Jism9* 525mg < & Mt9 250 mg < & Tt) 500mg < & 2', $ 4 #"s 4% @)nV9)V9* 30mg & ,m9$ 1g & C*)it9 500mg B<$ 2 #"s
A'$,/a W**) S2*%e
1 2 3 0-100 I0 I0 #/ m )i Fi0240 C7)n9sis n9n in m )i in Fi0240 ns% B+ 0 unAu)* ↓ t9 )Jsnt ,% Mus* n9n m9 m)$im)* .s E$ n9n m9 m)" #;Ving CJ)* $n 0 ss 9m) :)2
,)n B: ' ''
3%) ,% .lu&) %e$ <9 J*99 9 *)sm) t)nsusi9n
:*)sm) iit = J* 9* 'C 9* & ;t 'C 9* = J* 9* $ 0%4 G',<G F 'EF@EXE+ &4 ;7)ti &3 Jis" t;)n ))g &2 ))g n9m)* &1 ;79)ti 0 n9 s9ns
M.+C@E G',<G
: i ) 9 t s
.in 9utut = M2 $ ) . $ ; ,)g . = 25-30 / sA mt/; C)*9i 'At = 4000 $ M 2 $ Jun X 0%56 9ts Li > 50 +, Jun 9mut u t9 50 9n*7 Lst)t )ng9us i >15 +, is in9*
≥ imning s )i*u ≥ *us :)0 2 ≥65- $isting s )i*u
8 : i ) 9 t s
